Purchase Order 75D30123P16602

Award Date 6/15/23
Potential Completion Date 5/31/24
Potential Value $11K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morgantown, WV 26505, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price delivery order was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit subchapter S corporation. The $11,218.32 contract is for pathology support services, and does not have a set-aside designation. EPL is a contract research organization that specializes in toxicology pathology services and has a history of providing advanced scientific and laboratory services to various government...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization. The $12,650 contract is for microscopic evaluation of mouse tissue slides obtained from mice exposed to peroxyacetic acid aerosol. The contract does not have a set-aside designation, indicating EPL competed in an open federal procurement process. EPL has a long history of...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization. The contract, valued at $128,835.41, is for pathology support services and does not have a set-aside designation. EPL, which is registered in the System for Award Management (SAM) through January 2026, has extensive experience providing specialized...
This federal contract award, valued at $28,290.26, was issued by the U.S. Environmental Protection Agency's Office of Research and Development to Experimental Pathology Laboratories, Inc. (EPL), a for-profit Subchapter S corporation specializing in toxicology pathology services. The contract is for analysis and reporting of histology and pathology of rodent tissues following exposure to per- and polyfluoroalkyl substances (PFAS) in multiple samples of adult livers and kidneys, as well as pop...
This federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to Experimental Pathology Laboratories, Inc. (EPL), a for-profit Subchapter S corporation and contract research organization that specializes in providing toxicology pathology services to federal agencies. The $3,050.00 firm fixed-price purchase order contract is for a "DEFICIENCY OZONE STUDY" to be completed by July 31, 2024. The contract does not have a set-aside designation. EPL has been...
This is a firm fixed price purchase order contract awarded by the Environmental Protection Agency (EPA) Office of Research and Development to Experimental Pathology Laboratories, Inc. (EPL), a for-profit subchapter S corporation, to provide histology and pathology services for a male pubertal rodent study. The total potential value of the contract is $10,425.00 and the period of performance runs through July 31, 2024. EPL, a privately held and employee-owned contract research organization, has...
This federal contract award was issued by the U.S. Environmental Protection Agency (EPA) to Experimental Pathology Laboratories, Inc. (EPL), a for-profit subchapter S corporation that specializes in toxicology pathology services for government agencies. The $78,984.80 firm fixed-price purchase order is for EPA HISTOLOGY OF TISSUE SAMPLES, with a completion date of November 7, 2018. The contract is not designated as a set-aside. EPL has provided a range of specialized laboratory services to...
This firm fixed-price purchase order for $13,414.40 was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Experimental Pathology Laboratories, Inc. (EPL), a for-profit Subchapter S corporation. The contract is for veterinary services with a period of performance through July 9, 2024. EPL is a contract research organization that frequently supports federal agencies such as the CDC, Environmental Protection Agency, and National Institutes of Health by providing...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization based in Sterling, Virginia. The $403,303.54 contract is for pathology support services and does not have a set-aside designation. EPL has established itself as a critical research partner for various federal agencies, providing specialized technical capabilities in histology, pathology, and...
This is a cost-plus-fixed-fee contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Experimental Pathology Laboratories, Inc. (EPL) for the management and support of the NIEHS archives, frozen tissue bank, and specimen repository. The contract has a ceiling value of $41,581,952.47 and an ultimate completion date of March 28, 2025. The contract was set aside for total small business. EPL, a for-profit Subchapter S corporation, is a contract...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract for $11,430.96 to Experimental Pathology Laboratories, Inc. (EPL) for pathology services. The contract has a completion date of May 31, 2024 and does not have a set-aside designation. EPL is a for-profit, Subchapter S corporation that provides a comprehensive range of toxicology pathology services to federal agencies such as the Environmental Protection Agency, Centers for Disease Control and Prevention, National Institutes of Health, Food and Drug Administration, and Department of the Interior Fish and Wildlife Service. The contract is likely part of the CDC's broader toxicology programs that involve histopathological evaluation of tissues from rodent studies examining the impacts of chemicals like perfluoroalkyl and polyfluoroalkyl substances (PFAS), ozone exposure, and toxic substances.

Generated 6/1/24, 10:58 AM